Newsroom 
TERUMO Japan | 中文 | Size Small Big
Terumo Expands Peripheral Intervention Business

Terumo Concludes Co-development Agreement for PTA Balloon Catheters with Kaneka Corporation

 


 

Tokyo – Terumo Corporation (TSE: 4543 Section 1) announced that it has signed a co-development agreement for PTA balloon catheters with Kaneka Corporation (TSE: 4118 Section 1). Under the terms of the agreement, both companies will conduct product development. In addition, Kaneka will manufacturer and Terumo will then market the product across the globe. Commencing the sales in the U.S. market in fiscal 2014 and subsequently expanding the sales area and product portfolio, Terumo aims to achieve the revenue of 2.5 billion yen in fiscal 2016.

 

PTA (Percutaneous Transluminal Angioplasty)

 


Peripheral artery disease is associated with a blocked artery in the leg mainly caused by atherosclerosis. PTA is a procedure in which a small balloon at the end of thin catheter is inflated to restore blood flow. Since PTA is a minimally invasive therapy for the treatment of patients with peripheral artery disease, its application is expected to further expand worldwide.

 

Objectives of the co-development agreement

 


 

In 2011, Terumo concluded an OEM agreement with Kaneka Corporation for its PTA balloon catheter, Senri™ (currently marketed in Europe and Japan). Meanwhile, the co-development agreement at this time is not limited to one product but extends to a broad array of PTA balloon catheters varying for different applications and lesions. Kaneka Corporation is a top manufacturer of PTA balloon catheters in Japan with its high technology and product quality. On the other hand, Terumo has already introduced its peripheral stent Misago™ in Europe and Japan, in addition to its global sales of guide wires and introducer sheaths. By additionally expanding its PTA balloon catheter lineup, Terumo aims to further develop its business in peripheral vascular intervention.

(Notice) Among the information that Terumo discloses, forecasts of financial performance on future projections contain potential risks and uncertainty since these are forecasts on projections made by Terumo based on limited information available at the moment of disclosure. Accordingly, it should be noted that actual results may differ from those forecasts on projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.
Any market share information in this press release is partly derived from the company’s independent research.